BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10959911)

  • 1. Pyoderma gangrenosum in a child with myelodysplastic syndrome.
    Gümrük F; Tuncer MA; Hiĉsönmez G
    J Pediatr Hematol Oncol; 2000; 22(4):362-4. PubMed ID: 10959911
    [No Abstract]   [Full Text] [Related]  

  • 2. [A case of repeated pyoderma gangrenosum with myelodysplastic syndrome].
    Aoki M; Miura A; Sato I; Suzuki C
    Nihon Naika Gakkai Zasshi; 1993 Jan; 82(1):117-9. PubMed ID: 8459158
    [No Abstract]   [Full Text] [Related]  

  • 3. Pyoderma gangrenosum: an inflammatory ulcer.
    Samuel J; Williams C
    J Wound Care; 1996 Jul; 5(7):314-8. PubMed ID: 8954419
    [No Abstract]   [Full Text] [Related]  

  • 4. Pyoderma gangrenosum and myelodysplastic syndrome.
    Litvak D; Kirsner RS; Pakdaman NN; Federman DG
    South Med J; 2000 Sep; 93(9):923-5. PubMed ID: 11005358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of myelodysplastic syndrome-induced pyoderma gangrenosum.
    Koca E; Duman AE; Cetiner D; Buyukasik Y; Haznedaroglu IC; Uner A; Demirhan B; Kerimoglu U; Barista I; Calguneri M; Ozcebe OI
    Neth J Med; 2006 Dec; 64(11):422-4. PubMed ID: 17179573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythematous Bullous Patch in a Patient With Myelodysplastic Syndrome: Challenge.
    Hong JY; Park KY; Seo SJ
    Am J Dermatopathol; 2018 Aug; 40(8):e109-e110. PubMed ID: 28375856
    [No Abstract]   [Full Text] [Related]  

  • 7. Myelodysplastic syndrome, pyoderma gangrenosum, and Crohn disease.
    Sandoval C
    J Pediatr Hematol Oncol; 2001 May; 23(4):259-60. PubMed ID: 11846312
    [No Abstract]   [Full Text] [Related]  

  • 8. Multiple neutrophilic dermatoses in myelodysplastic syndrome.
    Vázquez García J; Almagro Sánchez M; Fonseca Capdevila E
    Clin Exp Dermatol; 2001 Jul; 26(5):398-401. PubMed ID: 11488825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bullous pyoderma gangrenosum in a patient with myelodysplastic syndrome during granulocyte colony-stimulating factor therapy.
    Lewerin C; Mobacken H; Nilsson-Ehle H; Swolin B
    Leuk Lymphoma; 1997 Aug; 26(5-6):629-32. PubMed ID: 9389372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyoderma gangrenosum with myelodysplastic syndrome treated with analogous bone marrow transplantation.
    Yamanaka K; Kuniyuki S; Maekawa N; Yoshida Y; Teshima H
    Acta Derm Venereol; 2009; 89(1):105-6. PubMed ID: 19197560
    [No Abstract]   [Full Text] [Related]  

  • 11. Articular and pancreatic involvement in pyoderma gangrenosum associated with myelodysplastic syndrome.
    Ochiai T; Hara H; Shimojima H; Fujitsuka A; Morishima T; Yamazaki T; Sawada U
    Dermatology; 2002; 205(1):70-2. PubMed ID: 12145440
    [No Abstract]   [Full Text] [Related]  

  • 12. Ulceration associated with stable myelodysplastic syndrome: atypical pyoderma gangrenosum?
    Harris A; O'hea AM; Burge S
    Clin Exp Dermatol; 1998 Nov; 23(6):293-5. PubMed ID: 10233632
    [No Abstract]   [Full Text] [Related]  

  • 13. Bullous pyoderma gangrenosum as the presenting sign of fatal acute myelogenous leukemia.
    Fox LP; Geyer AS; Husain S; Grossman ME
    Leuk Lymphoma; 2006 Jan; 47(1):147-50. PubMed ID: 16321840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyoderma gangrenosum after totally implanted central venous access device insertion.
    Inan I; Myers PO; Braun R; Hagen ME; Morel P
    World J Surg Oncol; 2008 Mar; 6():31. PubMed ID: 18325095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Image Gallery: Pyoderma gangrenosum in a patient with myelodysplastic syndrome treated with azacitidine.
    Pardo Pastor J; Redondo Capafons S; March López P; Nicolás Picó J; Pineda A; Martí JM
    Br J Dermatol; 2017 Sep; 177(3):e68. PubMed ID: 28940271
    [No Abstract]   [Full Text] [Related]  

  • 16. Pyoderma gangrenosum.
    Hambin TJ
    Lancet; 1998 Apr; 351(9109):1134. PubMed ID: 9660611
    [No Abstract]   [Full Text] [Related]  

  • 17. Coexistence of pustular and vegetative pyoderma gangrenosum in a patient with myelodysplastic syndrome.
    Omiya W; Ujiie H; Akiyama M; Izumi K; Shigematsu A; Onozawa M; Shimizu H
    Eur J Dermatol; 2012; 22(5):711-2. PubMed ID: 22858442
    [No Abstract]   [Full Text] [Related]  

  • 18. Clarithromycin for the treatment of pyoderma gangrenosum associated with myelodysplastic syndrome.
    Korekawa A; Nakajima K; Nakano H; Sawamura D
    J Dermatol; 2022 Apr; 49(4):e131-e132. PubMed ID: 34862670
    [No Abstract]   [Full Text] [Related]  

  • 19. Myeloid sarcoma developing in pre-existing pyoderma gangrenosum.
    Kristensen IB; Møller H; Kjaerskov MW; Yderstraede K; Møller MB; Bergmann OJ
    Acta Derm Venereol; 2009; 89(2):175-7. PubMed ID: 19326005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple nodules on the face and in the nasal cavity are the symptoms of vegetative pyoderma gangrenosum complicated with myelodysplastic syndrome.
    Murata J; Sato-Matsumura KC; Nishie W; Mayuzumi M; Kozaki S; Ohnishi K; Shibaki H
    Clin Exp Dermatol; 2006 Jan; 31(1):74-6. PubMed ID: 16309489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.